iRhythm Technologies, Inc.
Health
Performance
5.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

iRhythm Technologies, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

18.07.2026
Almost falling apart. Core metrics remain shaky and unstable.
17.07.2026
Signs of control returning. Still shaky, but not chaos.
15.07.2026
Losing steam. Not trending your way right now.
20.08.2025
Pulse detected. Still fragile, but stabilizing.
IRTC
iRhythm Technologies, Inc.
111.37
+0.44%
5.6
Sell
Buy
iRhythm Technologies, Inc.

iRhythm Technologies, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does iRhythm Technologies, Inc. do? Business model and key facts

Get the full picture of iRhythm Technologies, Inc.: what it builds, where it operates, and how it makes money.

iRhythm Technologies, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 2400

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.

shop
Company facts
Quentin S. Blackford
CEO
2400
Employees worldwide
shop
Performance
-17.82%
Last 12 months
112.34%
Last 5 years
shop
Growth
$747.14M
Revenue year
$-44,551,000
Net income
shop
Valuation
$3.64B
Market Cap
-127.65
Price/Earnings Ratio

Stocks related to iRhythm Technologies, Inc.

Selected based on industry alignment and relative market positioning.

LIVN
LivaNova PLC
79.21
-1.85%
3.8
Sell
Buy
LivaNova PLC
BIO
Bio-Rad Laboratories, Inc.
301.90
-0.81%
3.1
Sell
Buy
Bio-Rad Laboratories, Inc.
BRKR
Bruker Corporation
56.17
-3.54%
6.5
Sell
Buy
Bruker Corporation
ITGR
Integer Holdings Corporation
96.09
+0.70%
5.3
Sell
Buy
Integer Holdings Corporation
ESTA
Establishment Labs Holdings Inc.
93.42
+0.91%
6.1
Sell
Buy
Establishment Labs Holdings Inc.

Events and news impacting iRhythm Technologies, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

iRhythm Technologies, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.